Home › Novo obesity drug could launch in U.S. end 2014
 

Keywords :   


Novo obesity drug could launch in U.S. end 2014

2013-05-24 16:35:13| Biotech - Topix.net

Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the medicine's commercial potential.

Tags: end drug launch novo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.10Mark Andy appoints Antony Cotton European sales manager
07.10Hurricane Milton Potential Storm Surge Flooding Map
07.10Evonik, BASF Agree on First Delivery of Biomass-Balanced Ammonia
07.10Hurricane Milton Update Statement
07.10Summary for Hurricane Milton (AT4/AL142024)
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10MCC acquires smart label solutions provider Starport Technologies
07.10UPM Raflatac announces Packaging Recyclability Guide
More »